Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 478 (CSE: RAMM) (TSX: APHA) (NASDAQ: APHA), (OTC: MJNA)
Today's podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed cannabis cultivation and distribution company in Switzerland
Delta, Kelowna, BC - October 8, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 478 (CSE: RAMM) (TSX: APHA) (NASDAQ: APHA), (OTC: MJNA)
Today's podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today's podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's facilities for producing cannabis are based in Dietikon, Switzerland, and contain the art surveillance equipment to enable an around the clock webcast. Cannabis Suisse grows high quality, organic cannabis with sustainable, all-natural principles. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse proprietary trademarked MoldStandard is a quantitative microbiology method for analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked CannaMec is a method for quantifying and removing residual solvents during packaging and storage of CBD products. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
In today's podcast we look at a few public and private company announcements.
Aphria Inc. (TSX: APHA) (NASDAQ: APHA), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, announced that it has completed its first certified European Union Good Manufacturing Practices ("EU GMP") shipment of dried flower from its Aphria One EU GMP facility to its wholly-owned German subsidiary, CC Pharma GmbH, a leading distributor of pharmaceutical products to more than 13,000 pharmacies in Germany.
"Our first EU GMP shipment into Germany represents another significant milestone for Aphria Inc., one that strengthens our position as a leading cannabis company in Germany and in the European Union," said Irwin D. Simon, Chief Executive Officer, Aphria Inc. "We are leveraging our strong medical platform and multi-faceted German strategy, which combines domestic cultivation, import licenses and large distribution infrastructure, to increase access to high-quality medical cannabis for patients worldwide. We remain excited about future milestones, including the completion of our cultivation facility in Neumunster, Germany, which we expect will be completed in Q2 FY2021."
The German market is considered to be one of the most highly sought-after developed medical cannabis markets in the world. Aphria's German operations have been preparing for the importation of EU-GMP certified cannabis from Canada, allowing for shipments to CC Pharma in order to leverage CC Pharma's expansive in-country distribution network.
Pabst Labs, a newly formed licensed cannabis company, has revealed the initial launch of Pabst Blue Ribbon Cannabis Infused Seltzer. The famed Blue Ribbon, synonymous with good times for over 175 years, will now adorn the can of a non-alcoholic THC infused seltzer developed by Pabst Labs.
Pabst Labs was founded by a group of cannabis beverage experts and former Pabst Brewing Company employees who were granted the rights to create a line of cannabis infused drinks under the Pabst Blue Ribbon Name. Pabst Labs is responsible for the production, marketing and sales of the new drink.
"Pabst Blue Ribbon has an incredibly loyal and passionate customer base who are open to change and embracing new ideas. We've spent a long time creating a quality product for both new and experienced users, and believe the entry of an established brand can help kick-start the cannabis drinks category," said Mark Faicol, Pabst Labs Brand Manager.
Pabst Blue Ribbon Cannabis Infused Seltzer marks a major milestone for the burgeoning cannabis drinks industry, and an awesome way for lovers of Pabst Blue Ribbon to experiment with a new kind of buzz. The initial test launch will see Pabst Blue Ribbon Cannabis Infused Seltzer available for customers in a select group of California dispensaries and direct to California consumers via shop.PabstLabs.com.
Pabst Labs is thrilled and honored to develop a product that's fit to use the famed Pabst Blue Ribbon name. Pabst Blue Ribbon is one of America's most beloved brands, a champion of the creative community and lifestyle, and recently has been innovating beyond beer, with the launches of Hard Coffee, Hard Tea and Harder Seltzer.
Pabst Blue Ribbon's willingness to experiment and push boundaries led Pabst Labs to enquire about collaborating, and a shared passion for quality and innovation ultimately led to Pabst Labs being granted the rights to create a line of cannabis infused drinks worthy of the Blue Ribbon.
Each 12 oz can of Pabst Blue Ribbon Cannabis Infused Seltzer is made from the highest-quality ingredients and serves up a delicious effervescent lemon-flavored seltzer that contains just 4 grams of sugar, 25 calories and contains no preservatives. With 5 mg of THC per can Pabst Labs has ensured it offers up a responsible dosage designed to make it a go to drink for both casual and experienced cannabis users. The lemon seltzer will be the only flavor available during initial launch, but additional flavors are already in development.
"Though this is a limited initial launch, we've had a really enthusiastic and positive response from dispensaries and customers, and are looking forward to a wider roll out in the coming months. For over 175 years the Blue Ribbon has connected fans across generations around its products, and we think customers, new and old, are going to love the chance to experiment with something different from a brand they trust," concluded Faicol.
RAMM Pharma Corp. (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical products, announced that the Company has commenced sales of its Epifractan™ products through Peruvian pharmacies. As announced on July 9th and 16th, 2020, Epifractan™ was approved and registered by Peru's Ministry of Health (Ministerio de Salud or "MINSA"), becoming one of only a few cannabis products registered in the country. Both Epifractan™ 2% and Epifractan™ 5% have now been shipped to Peru for sale through pharmacies and will be available to patients with a medical prescription.
RAMM also continues to scale up regular shipments of Epifractan™ to Brazil under the country's compassionate use framework.
"Sales of our registered medical products through pharmacies is significant to expanding their accessibility to patients in new markets," stated Jack Burnett, Chief Executive Officer.
Epifractan™ was approved and registered in Peru upon the completion of rigorous testing requirements and approval by MINSA to certify consistency, stability and effective shelf life. Registered products are available at pharmacies as branded finished products and should not be confused with magistral formulas which are prepared by a pharmacist on a case-by-case basis and have not received MINSA approval and registration. Currently only very few cannabidiol products have been granted MINSA registration in Peru.
Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Raul Elizalde, the co-CEO of subsidiary HempMeds®, was featured in global financial news outlet Reuters discussing the future of Mexico's legal cannabis industry.
The October 1, 2020, Reuters article entitled "Mexico, plagued by cartel wars, on cusp of legal cannabis 'green rush'" provided coverage on pending legislation in Mexico that would make the country legal for both medicinal and recreational use. Though HempMeds® is listed in the article as a large player that is looking to get involved in these new markets, the Company has been operating and selling high-quality cannabidiol (CBD) products there for the past four years and was the first to legally import CBD to consumers in Mexico under a federal government import permit in 2016.
"We've made great progress in Latin America, specifically Mexico and Brazil, and are excited to see how different Mexico's legal cannabis market looks in just a few short months," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "We will continue to offer the highest-quality products and look forward to finding new ways to expand our footprint and offerings in Mexico."
According to the article, there may soon be a huge influx of large U.S. and Canadian cannabis companies breaking into Mexico's legal cannabis market, as well as local entrepreneurs who want to get involved. Though there is a long history of Mexico's drug cartel influence, with these new laws the country would be able to fuel legal cannabis businesses selling in privately run sales and distribution centers.
Once again, today's podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Disclosure: Cannabis Suisse Corp. (OTC: CSUI),is a paid featured company on Investorideas.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android